Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uncontrolled Gout”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Post-approval studies (Phase 4)Study completedNCT06229145
What this trial is testing

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

Who this might be right for
Gout
Amgen 262
Post-approval studies (Phase 4)Study completedNCT03994731
What this trial is testing

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

Who this might be right for
Gout
Amgen 152
Post-approval studies (Phase 4)Study completedNCT04511702
What this trial is testing

Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

Who this might be right for
Chronic Uncontrolled GoutGoutUncontrolled Gout
Amgen 191
Post-approval studies (Phase 4)Study completedNCT04762498
What this trial is testing

A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)

Who this might be right for
Uncontrolled GoutChronic Gout
Amgen 50
Post-approval studies (Phase 4)Study completedNCT03635957
What this trial is testing

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

Who this might be right for
Gout
Amgen 14
Post-approval studies (Phase 4)Study completedNCT04087720
What this trial is testing

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

Who this might be right for
Uncontrolled GoutKidney Transplant
Amgen 20
Post-approval studies (Phase 4)Study completedNCT04772313
What this trial is testing

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

Who this might be right for
Uncontrolled Gout
Amgen 11
Early research (Phase 1)Looking for participantsNCT06298071
What this trial is testing

A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.

Who this might be right for
Gout
Shanghai Institute Of Biological Products 36
Testing effectiveness (Phase 2)Looking for participantsNCT07116746
What this trial is testing

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Who this might be right for
GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics 25
Large-scale testing (Phase 3)Looking for participantsNCT07388498
What this trial is testing

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

Who this might be right for
Uncontrolled Gout
Amgen 270